Skip to content
PTGX Protagonist Therapeutics, Inc
$102.16 -3.33% -3.51
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PTGX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 6.6B
Enterprise value 6.0B
Trailing PE 139.51515
Forward PE -114.67885
PEG Ratio -1.06031514
Enterprise to EBITDA -42.784
Enterprise to revenue 81.462
Price to book MRQ 10.011758
Price to sales TTM 88.7263

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 74.1M
EBITDA -141016992
Diluted EPS TTM -1.81
Total Cash (MRQ) 547.8M
Current ratio (MRQ) 17.756
Operating Cash Flow (TTM) -116635000

PTGX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PTGX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.